UPDATE 1-FDA panel unanimously backs Novartis' copy of Amgen's Neupogen

Jan 7 (Reuters) - A panel to the U.S. Food and Drug Administration unanimously backed the approval of Novartis AG's copy of Amgen Inc's blockbuster cancer drug Neupogen, setting the stage for the...